Nucleic Acid HIV/HCV Testing Advocated As Supplemental Blood Screen
This article was originally published in The Gray Sheet
Executive Summary
FDA will weigh options allowing HIV and hepatitis C nucleic acid testing to become the confirmatory test for blood donors with a repeatedly reactive enzyme immunoassay (EIA) screening result